GlassScriptPhysician profile
Cristian Enescu
NPI 1518920925
$5,616.57
in general payments reported to CMS, 2019-2025
40 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $575 · 2021: $1,853 · 2022: $1,464 · 2023: $749 · 2024: $409 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,192 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.69 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $832.57 | 2020-2024 | Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $460.35 | 2019-2023 | |
| Sk Life Science, INC. | $412.10 | 2020-2022 | |
| Abbvie INC. | $355.43 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $312.38 | 2020-2022 | |
| Ucb, INC. | $310.61 | 2019-2023 | Briviact, Nayzilam |
| Jazz Pharmaceuticals INC. | $305.13 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $258.60 | 2020-2022 | |
| Biogen, INC. | $246.94 | 2019-2023 | Vumerity |
| Biohaven Pharmaceutical Holding Company LTD. | $243.72 | 2022 | |
| Amgen INC. | $226.38 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $208.95 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $178.72 | 2020-2024 | Ingrezza, Ongentys |
| Pfizer INC. | $150.23 | 2023 | |
| Avanir Pharmaceuticals, INC. | $133.28 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cristian Enescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.